Status:
RECRUITING
SURGE: Supporting UnderRepresented Minorities in Genomics-based Cancer Trial Enrollment (Intervention)
Lead Sponsor:
Nadine McCleary, MD, MPH
Collaborating Sponsors:
Bristol-Myers Squibb
Conditions:
Gastrointestinal Cancer
Hematologic Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
SURGE aims to increase equity in clinical trial enrollment by addressing barriers to genomic testing, which is increasingly needed to assess precision clinical trial eligibility and access standard pr...
Detailed Description
Supporting UnderRepresented populations in Genomics-based cancer trial Enrollment (SURGE) is a multimodal intervention to address medical literacy and unmet social determinants of health (SDoH) needs ...
Eligibility Criteria
Inclusion
- Adult (age 18 years or older)
- Black, Latinx, OR older adult (age 70 years or older)
- Scheduled for a new patient consultation
- Suspected or confirmed advanced malignancy (requiring active treatment)
- Gastrointestinal, hematologic, or thoracic cancer
- DFCI patient at Longwood/Chestnut Hill, DFCI satellite at St. Elizabeth's Medical Center, or DFCI satellite at Merrimack Valley
Exclusion
- Malignancy or former malignancy that requires only surveillance
- Not continuing care at a participating DFCI site
- Speaks a language other than English or Spanish
- Unable to provide consent
Key Trial Info
Start Date :
April 3 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 30 2028
Estimated Enrollment :
210 Patients enrolled
Trial Details
Trial ID
NCT05375643
Start Date
April 3 2023
End Date
July 30 2028
Last Update
November 5 2025
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Dana Farber Cancer Institute
Boston, Massachusetts, United States, 02215
2
Dana-Farber Cancer Institute at St. Elizabeth's Medical Center
Brighton, Massachusetts, United States, 02135
3
Dana-Farber Cancer Instiute - Merrimack Valley
Methuen, Massachusetts, United States, 01844